Can a 12-Week online course help babies with SMA develop better?
NCT ID NCT07547189
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 12-week online program for mothers of infants (12-36 months old) with SMA Type 1. The program aims to teach mothers how to support their baby's development and improve their own knowledge. Thirteen mothers will take part, with 10 receiving the program and 3 receiving standard care. Researchers will measure the babies' developmental progress and the mothers' understanding of child development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Online Early Intervention Program for Infants with SMA Type 1
What this could lead to
If it works, this could provide a practical way for mothers to help their infants with SMA reach developmental milestones and improve their own understanding of child development.
What could go wrong
This is a very small pilot study with only 13 participants, so results may not apply to others. The program is behavioral support, not a medical treatment, and may not change the underlying disease course.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ISTANBUL MEDIPOL UNIVERSITY - Department of Child Development
Istanbul, Beykoz, Turkey (Türkiye)